Standard BioTools (LAB) Revenue & Revenue Breakdown
Standard BioTools Revenue Highlights
Latest Revenue (Y)
$106.34M
Latest Revenue (Q)
$37.20M
Main Segment (Y)
Product And Service
Main Geography (Y)
Americas
Standard BioTools Revenue by Period
Standard BioTools Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $106.34M | 8.57% |
| 2022-12-31 | $97.95M | -24.99% |
| 2021-12-31 | $130.58M | -5.47% |
| 2020-12-31 | $138.14M | 17.83% |
| 2019-12-31 | $117.24M | 3.79% |
| 2018-12-31 | $112.96M | 10.82% |
| 2017-12-31 | $101.94M | -2.40% |
| 2016-12-31 | $104.45M | -8.95% |
| 2015-12-31 | $114.71M | -1.50% |
| 2014-12-31 | $116.46M | 63.60% |
| 2013-12-31 | $71.18M | 36.02% |
| 2012-12-31 | $52.33M | 22.09% |
| 2011-12-31 | $42.87M | 27.73% |
| 2010-12-31 | $33.56M | 32.06% |
| 2009-12-31 | $25.41M | 65.58% |
| 2008-12-31 | $15.35M | 110.96% |
| 2007-12-31 | $7.28M | 13.71% |
| 2006-12-31 | $6.40M | -95.10% |
| 2001-12-31 | $130.58M | - |
Standard BioTools generated $106.34M in revenue during NA 2023, up 8.57% compared to the previous quarter, and up 94.14% compared to the same period a year ago.
Standard BioTools Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $37.20M | -18.30% |
| 2024-03-31 | $45.54M | 61.56% |
| 2023-12-31 | $28.19M | 11.12% |
| 2023-09-30 | $25.37M | -8.31% |
| 2023-06-30 | $27.67M | 10.14% |
| 2023-03-31 | $25.12M | -7.04% |
| 2022-12-31 | $27.02M | 5.36% |
| 2022-09-30 | $25.65M | 36.58% |
| 2022-06-30 | $18.78M | -29.15% |
| 2022-03-31 | $26.50M | -30.74% |
| 2021-12-31 | $38.27M | 34.24% |
| 2021-09-30 | $28.50M | -8.10% |
| 2021-06-30 | $31.02M | -5.42% |
| 2021-03-31 | $32.79M | -26.48% |
| 2020-12-31 | $44.61M | 11.91% |
| 2020-09-30 | $39.86M | 52.97% |
| 2020-06-30 | $26.06M | -5.65% |
| 2020-03-31 | $27.62M | -14.87% |
| 2019-12-31 | $32.44M | 22.43% |
| 2019-09-30 | $26.50M | -6.03% |
| 2019-06-30 | $28.20M | -6.36% |
| 2019-03-31 | $30.11M | -6.85% |
| 2018-12-31 | $32.33M | 11.61% |
| 2018-09-30 | $28.96M | 9.59% |
| 2018-06-30 | $26.43M | 4.67% |
| 2018-03-31 | $25.25M | -9.00% |
| 2017-12-31 | $27.75M | 12.11% |
| 2017-09-30 | $24.75M | 3.49% |
| 2017-06-30 | $23.91M | -6.35% |
| 2017-03-31 | $25.53M | 1.79% |
| 2016-12-31 | $25.08M | 13.04% |
| 2016-09-30 | $22.19M | -21.22% |
| 2016-06-30 | $28.17M | -2.88% |
| 2016-03-31 | $29.00M | -5.60% |
| 2015-12-31 | $30.72M | 7.26% |
| 2015-09-30 | $28.64M | 0.09% |
| 2015-06-30 | $28.62M | 7.07% |
| 2015-03-31 | $26.73M | -20.19% |
| 2014-12-31 | $33.49M | 13.01% |
| 2014-09-30 | $29.64M | 7.35% |
| 2014-06-30 | $27.61M | 7.32% |
| 2014-03-31 | $25.72M | 23.19% |
| 2013-12-31 | $20.88M | 14.18% |
| 2013-09-30 | $18.29M | 4.62% |
| 2013-06-30 | $17.48M | 20.26% |
| 2013-03-31 | $14.54M | -7.18% |
| 2012-12-31 | $15.66M | 22.51% |
| 2012-09-30 | $12.78M | -1.28% |
| 2012-06-30 | $12.95M | 18.30% |
| 2012-03-31 | $10.95M | -15.78% |
| 2011-12-31 | $13.00M | 22.65% |
| 2011-09-30 | $10.60M | 0.19% |
| 2011-06-30 | $10.58M | 21.61% |
| 2011-03-31 | $8.70M | -16.01% |
| 2010-12-31 | $10.36M | 22.31% |
| 2010-09-30 | $8.47M | 5.52% |
| 2010-06-30 | $8.02M | 19.46% |
| 2010-03-31 | $6.72M | -11.90% |
| 2009-12-31 | $7.62M | - |
Standard BioTools generated $37.20M in revenue during Q2 2024, up -18.30% compared to the previous quarter, and up 148.11% compared to the same period a year ago.
Standard BioTools Revenue Breakdown
Standard BioTools Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Consumables | $41.74M | $46.79M | $57.88M | $45.41M | - |
| Service | $25.98M | $23.71M | $25.92M | $22.58M | $21.28M |
| Product | $79.20M | $72.45M | $100.38M | $99.94M | $95.42M |
| Product and Service, Other | $1.16M | $964.00K | $1.73M | $6.76M | - |
| Product And Service | $105.18M | $96.17M | - | - | - |
| Instruments | $37.46M | $25.66M | $42.50M | $50.00M | - |
| License | - | $964.00K | $147.00K | - | - |
| Grant | - | - | $1.58M | - | - |
| Collaboration Revenue | - | $818.00K | $2.56M | - | - |
| Grant Revenue | - | - | - | - | $550.00K |
Standard BioTools's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product And Service (36.18%), Product (27.24%), Consumables (14.36%), Instruments (12.89%), Service (8.94%), and Product and Service, Other (0.40%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration and Other Revenue | $921.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Instruments | $4.90M | $16.87M | $9.00M | $11.59M | $2.66M | $7.52M | $14.55M | $10.06M | $10.18M | $7.71M | $12.62M | $8.58M | $9.47M | $15.80M | $9.16M | $12.20M | $12.84M | - | - | - |
| Service | $21.03M | $13.59M | $6.57M | $5.82M | $5.91M | $5.86M | $5.81M | $6.14M | $6.99M | $6.02M | $6.63M | $6.29M | $6.12M | $6.13M | $5.14M | $5.19M | $5.40M | $5.63M | $4.96M | $5.28M |
| Product | $23.59M | $38.82M | $18.71M | $21.66M | $20.92M | $19.31M | $12.22M | $20.00M | $31.08M | $21.94M | $22.63M | $24.73M | $34.35M | $29.21M | $17.41M | $18.98M | $26.69M | $20.67M | $23.23M | - |
| Product And Service | $44.62M | $52.41M | $25.28M | $27.49M | $26.82M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Consumables | $10.41M | $21.95M | $9.71M | $10.08M | $9.56M | $12.48M | $16.53M | $11.88M | $12.45M | $17.02M | $16.59M | $8.83M | $9.51M | $10.88M | $11.51M | $11.03M | $11.99M | - | - | - |
| Product and Service, Other | - | $892.00K | $90.00K | $180.00K | $-621.00K | $396.00K | $268.00K | $54.00K | $461.00K | $914.00K | $300.00K | $1.45M | $1.34M | $513.00K | - | - | - | - | - | - |
| Collaboration Revenue | - | - | - | - | - | - | $356.00K | $88.00K | $139.00K | $90.00K | $1.48M | $2.69M | $3.18M | $3.00M | - | - | - | - | - | - |
| License | - | - | - | - | - | - | $396.00K | $268.00K | $54.00K | - | $93.00K | - | - | $63.00K | - | - | - | - | - | - |
| Grant | - | - | - | - | - | - | - | - | - | $461.00K | $821.00K | $300.00K | $1.34M | $450.00K | - | - | - | - | - | - |
| Grant Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $350.00K | $350.00K | $200.00K | - | - |
| Total Products | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $24.83M |
Standard BioTools's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product And Service (42.30%), Product (22.37%), Service (19.94%), Consumables (9.87%), Instruments (4.65%), and Collaboration and Other Revenue (0.87%).
Standard BioTools Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Asia Pacific | $23.94M | $20.83M | $23.98M | $25.78M | $30.20M |
| EMEA | $36.20M | $33.14M | $42.72M | $37.78M | $40.02M |
| Americas | $46.20M | $43.98M | $63.88M | $74.59M | $47.02M |
Standard BioTools's latest annual revenue breakdown by geography, as of Dec 23: Americas (43.44%), EMEA (34.04%), and Asia Pacific (22.52%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific | $8.36M | $6.20M | $6.34M | $5.78M | $5.62M | $5.74M | $6.45M | $3.67M | $4.96M | $7.79M | $5.38M | $5.68M | $5.13M | $8.17M | $7.37M | $5.56M | $4.68M | $9.07M | $6.29M | $5.86M |
| EMEA | $12.52M | $8.77M | $8.16M | $11.44M | $7.84M | $10.78M | $8.07M | $5.67M | $8.61M | $14.25M | $10.11M | $9.22M | $9.14M | $14.29M | $8.84M | $6.56M | $8.10M | - | - | - |
| Americas | $24.66M | $13.22M | $10.87M | $10.45M | $11.66M | $10.50M | $11.12M | $9.43M | $12.93M | $16.22M | $13.01M | $16.12M | $18.52M | $22.15M | $23.65M | $13.94M | $14.84M | $11.81M | $11.11M | $11.12M |
| Europe | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.09M | $11.22M |
Standard BioTools's latest quarterly revenue breakdown by geography, as of Mar 24: Americas (54.16%), EMEA (27.48%), and Asia Pacific (18.36%).
Standard BioTools Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| GTH | Genetron | $650.71M | $201.32M |
| NOTV | Inotiv | $572.42M | $105.79M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| LMDX | LumiraDx | $254.48M | $21.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| LAB | Standard BioTools | $106.34M | $37.20M |
| FONR | FONAR | $98.65M | $25.72M |
| STIM | Neuronetics | $71.35M | $16.45M |
| MDXH | MDxHealth SA | $70.19M | $19.83M |
| BDSX | Biodesix | $49.09M | $14.82M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| SERA | Sera Prognostics | $306.00K | - |
| NDRA | ENDRA Life Sciences | - | - |
LAB Revenue FAQ
What is Standard BioTools’s yearly revenue?
Standard BioTools's yearly revenue for 2023 was $106.34M, representing an increase of 8.57% compared to 2022. The company's yearly revenue for 2022 was $97.95M, representing a decrease of -24.99% compared to 2021. LAB's yearly revenue for 2021 was $130.58M, representing a decrease of -5.47% compared to 2020.
What is Standard BioTools’s quarterly revenue?
Standard BioTools's quarterly revenue for Q2 2024 was $37.2M, a -18.30% decrease from the previous quarter (Q1 2024), and a 34.48% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $45.54M, a 61.56% increase from the previous quarter (Q4 2023), and a 81.30% increase year-over-year (Q1 2023). LAB's quarterly revenue for Q4 2023 was $28.19M, a 11.12% increase from the previous quarter (Q3 2023), and a 4.32% increase year-over-year (Q4 2022).
What is Standard BioTools’s revenue growth rate?
Standard BioTools's revenue growth rate for the last 3 years (2021-2023) was -18.56%, and for the last 5 years (2019-2023) was -9.30%.
What are Standard BioTools’s revenue streams?
Standard BioTools's revenue streams in c 23 are Consumables, Service, Product, Product and Service, Other, Product And Service, and Instruments. Consumables generated $41.74M in revenue, accounting 14.36% of the company's total revenue, down -10.80% year-over-year. Service generated $25.98M in revenue, accounting 8.94% of the company's total revenue, up 9.56% year-over-year. Product generated $79.2M in revenue, accounting 27.24% of the company's total revenue, up 9.31% year-over-year. Product and Service, Other generated $1.16M in revenue, accounting 0.40% of the company's total revenue, up 20.54% year-over-year. Product And Service generated $105.18M in revenue, accounting 36.18% of the company's total revenue, up 9.37% year-over-year. Instruments generated $37.46M in revenue, accounting 12.89% of the company's total revenue, up 45.96% year-over-year.
What is Standard BioTools’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Standard BioTools was Product And Service. This segment made a revenue of $105.18M, representing 36.18% of the company's total revenue.